Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ann-Kathrin Reuschlein
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients With Multiple Sclerosis
PLoS ONE
Multidisciplinary
Related publications
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients With Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
PLoS ONE
Multidisciplinary
Interferon Inhibitory Activity in Patients With Multiple Sclerosis
Archives of Neurology
Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis
Endocrine Regulations
Endocrinology
Metabolism
Diabetes
Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Stem Cells International
Cell Biology
Molecular Biology
Time to Plateau as a Predictor of Survival in Newly Diagnosed Multiple Myeloma
American Journal of Hematology
Hematology
A Case Followed as Having Multiple Sclerosis but Diagnosed With Secondary Brain Lymphoma
Turk Noroloji Dergisi
Neurology
Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Chromosome 1 Abnormalities in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Therapies
Haematologica
Hematology
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
